Deutetrabenazine
TV50717-NDG-40182
Approved small_molecule completed
Quick answer
Deutetrabenazine for Huntington's Disease is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Huntington's Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed